Anne A. Finucane - 15 Nov 2023 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role: Director
Signature: /s/ Anne M. Finucane
Issuer symbol: CVS
Transactions as of: 15 Nov 2023
Net transactions value: +$133,075
Form type: 4
Filing time: 17 Nov 2023, 16:48:49 UTC
Previous filing: 31 Oct 2023
Next filing: 08 Dec 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CVS	Common Stock	Award	$133,075	+1,925	+22%	$69.13	10,682	15 Nov 2023	Direct	F1
holding	CVS	Common Stock						25,198	15 Nov 2023	By Finucane Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	CVS	Share Credits						7,409	15 Nov 2023	Common Stock	7,409	$0.000000	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.
F2	Consists of deferred stock compensation payable pursuant to Reporting Person's election.